Benzyl 2-(5-methylpyridin-3-yl)piperidine-1-carboxylate

Catalog No.: 
ACLSVI513
CAS No.: 
1352524-32-3
Molecular Formula: 
C19H22N2O2
Molecular Weight: 
310.40
Benzyl 2-(5-methylpyridin-3-yl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$338.00InquiryInquiry
1g97%$986.00InquiryInquiry
5g97%$4881.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzyl 2-(5-methylpyridin-3-yl)piperidine-1-carboxylate
IUPAC Namebenzyl 2-(5-methylpyridin-3-yl)piperidine-1-carboxylate
Molecular FormulaC19H22N2O2
Molecular Weight310.40
SMILESO=C(N1CCCCC1C2=CC(C)=CN=C2)OCC3=CC=CC=C3
InChI KeyHNTPZDWGWYAVJU-UHFFFAOYSA-N
Synonym5-Methyl-3,4,5,6-tetrahydro-2H-[2,3]bipyridinyl-1-carboxylic acid benzyl ester;1-Piperidinecarboxylic acid, 2-(5-methyl-3-pyridinyl)-, phenylmethyl ester
CAS No.1352524-32-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLSVI513 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLSVI513 route product structure diagram
    ACLSVI5131352524-32-3
Inquiry

2. ACLSVI513 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLSVI513 route product structure diagram
    ACLSVI5131352524-32-3
Inquiry

3. ACLSVI513 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLSVI513 route product structure diagram
    ACLSVI5131352524-32-3
Inquiry

Comments (0)